Impaired intratumoral natural killer cell function in head and neck carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impaired intratumoral natural killer cell function in head and neck carcinoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-10-20
DOI
10.3389/fimmu.2022.997806
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
- (2022) Diwakar Davar et al. CLINICAL CANCER RESEARCH
- Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?
- (2022) Alhadi Almangush et al. Cancers
- Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
- (2021) Daniele Borsetto et al. Cancers
- Prognostic Potential of Tumor-Infiltrating Immune Cells in Resectable Oral Squamous Cell Carcinoma
- (2021) Ana Caruntu et al. Cancers
- Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
- (2021) Minli Niu et al. Radiation Oncology
- CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell
- (2021) Binglin Wang et al. Journal for ImmunoTherapy of Cancer
- Siglec-7 is an indicator of natural killer cell function in acute myeloid leukemia
- (2021) Liu Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
- (2021) Guangyu Lian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Assessment of Immune Cell Populations in Tumor Tissue and Peripheral Blood Samples from Head and Neck Squamous Cell Carcinoma Patients
- (2021) Ana Caruntu et al. Analytical Cellular Pathology
- Reduced Siglec‐7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma
- (2020) L. Tao et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma
- (2020) Jie Wang et al. BMC CANCER
- Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy
- (2020) Lisa K. Puntigam et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Unique immunological profile in patients with COVID-19
- (2020) Stefania Varchetta et al. Cellular & Molecular Immunology
- Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
- (2020) Ani S. Balmanoukian et al. CLINICAL CANCER RESEARCH
- Digital Image Analysis of CD8+ and CD3+ Tumor-Infiltrating Lymphocytes in Tongue Squamous Cell Carcinoma
- (2020) Yenlin Huang et al. Cancer Management and Research
- Memory NK Cell Features Exploitable in Anticancer Immunotherapy
- (2019) Cristina Capuano et al. Journal of Immunology Research
- Targeting natural killer cells in solid tumors
- (2019) Guillaume Habif et al. Cellular & Molecular Immunology
- Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis
- (2019) Elin Hadler-Olsen et al. BRITISH JOURNAL OF CANCER
- Evaluation of Cd8+ and natural killer cells defense in oral and oropharyngeal squamous cell carcinoma
- (2019) Edilmar Moura Santos et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Rational design of anti-GITR-based combination immunotherapy
- (2019) Roberta Zappasodi et al. NATURE MEDICINE
- Characterization and comparison of GITR expression in solid tumors
- (2019) Luis Vence et al. CLINICAL CANCER RESEARCH
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma
- (2019) Matthew E. Spector et al. JAMA Otolaryngology-Head & Neck Surgery
- Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
- (2019) Jesús García-Foncillas et al. Frontiers in Oncology
- Harnessing innate immunity in cancer therapy
- (2019) Olivier Demaria et al. NATURE
- Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor–Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors
- (2019) Kimberley M. Heinhuis et al. JAMA Oncology
- TIGIT as an emerging immune checkpoint
- (2019) H. Harjunpää et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma
- (2018) Juan Lu et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
- (2018) Quirin Hammer et al. NATURE IMMUNOLOGY
- Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
- (2018) Lucas Ferrari de Andrade et al. SCIENCE
- Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37
- (2018) Dhifaf Sarhan et al. Cancer Immunology Research
- Distinct HLA-E Peptide Complexes Modify Antibody-Driven Effector Functions of Adaptive NK Cells
- (2018) Alexander Rölle et al. Cell Reports
- Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma
- (2018) Jacqueline E. Mann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
- (2018) Nadine van Montfoort et al. CELL
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
- (2018) Fernando Concha-Benavente et al. Cancer Immunology Research
- Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity
- (2017) Barbara Oliviero et al. JOURNAL OF HEPATOLOGY
- IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation
- (2017) Evan Lusty et al. MOLECULAR IMMUNOLOGY
- Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma
- (2017) Sandra Weil et al. Frontiers in Immunology
- Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells
- (2016) Dhifaf Sarhan et al. CANCER RESEARCH
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma
- (2016) Steffen Wagner et al. INTERNATIONAL JOURNAL OF CANCER
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities
- (2016) J.-Y. Shao et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Harnessing NK Cell Memory for Cancer Immunotherapy
- (2016) Todd A. Fehniger et al. TRENDS IN IMMUNOLOGY
- High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
- (2016) Cheng Sun et al. OncoImmunology
- CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
- (2016) Kerstin A. Stegmann et al. Scientific Reports
- Negative regulation of natural killer cell in tumor tissue and peripheral blood of oral squamous cell carcinoma
- (2015) Anupam Dutta et al. CYTOKINE
- Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection
- (2015) Stefania Varchetta et al. GUT
- Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
- (2015) Heinrich Schlums et al. IMMUNITY
- Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals
- (2015) Jaewon Lee et al. IMMUNITY
- Prognostic implication of CD57, CD16, and TGF-β expression in oral squamous cell carcinoma
- (2015) Nasim Taghavi et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
- (2015) F Cichocki et al. LEUKEMIA
- Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue
- (2015) Martin Grimm et al. TUMOR BIOLOGY
- Increased sMICA and TGFβ1levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells
- (2015) Stephan Klöß et al. OncoImmunology
- IL-12–producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion
- (2014) Alexander Rölle et al. JOURNAL OF CLINICAL INVESTIGATION
- The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center
- (2014) Michel C. van Harten et al. ORAL ONCOLOGY
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
- (2013) M J Ward et al. BRITISH JOURNAL OF CANCER
- Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen-Specific T-cell Immunity in Head and Neck Cancer Patients
- (2013) R. M. Srivastava et al. CLINICAL CANCER RESEARCH
- Natural cytotoxicity receptors and their ligands
- (2013) Philip H Kruse et al. IMMUNOLOGY AND CELL BIOLOGY
- Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer
- (2013) Zi-Jun Zhen et al. MEDICAL ONCOLOGY
- IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients
- (2012) B. Schilling et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CMV drives clonal expansion of NKG2C+NK cells expressing self-specific KIRs in chronic hepatitis patients
- (2011) Vivien Béziat et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
- (2010) Silke Paust et al. NATURE IMMUNOLOGY
- Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis
- (2010) D. Pulte et al. ONCOLOGIST
- Adaptive immune features of natural killer cells
- (2009) Joseph C. Sun et al. NATURE
- Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma
- (2009) Ajay Matta et al. Head and Neck Optical Diagnostics Society
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search